{"transactions":[{"id":4617655,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-15T10:33:04.000Z","date":"2026-09-14","kind":"purchase","planned":false,"acquired":true,"shares":73000,"price":1.37,"value":100010.0,"ownership":{"direct":true},"balance_after":1049121,"source":{"system":"sec-edgar","filing":"0001878313-26-000087","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1913257/000187831326000087/form4.xml","form_type":"4"}},{"id":755129,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-02T13:02:16.000Z","date":"2026-06-01","kind":"purchase","planned":false,"acquired":true,"shares":72700,"price":1.3877,"value":100885.79,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $1.3634 to $1.4150, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":976121,"source":{"system":"sec-edgar","filing":"0001878313-26-000062","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000062/form4.xml","form_type":"4"}},{"id":757259,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2026-06-01T12:54:27.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on May 29, 2026 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary date of the grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":800000,"derivative":{"exercise_price":1.39,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001878313-26-000053","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000053/form4.xml","form_type":"4"}},{"id":808889,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2026-04-14T12:45:39.000Z","date":"2026-04-10","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on April 10, 2026 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary date of the grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":800000,"derivative":{"exercise_price":1.28,"exercise_date":"2027-04-10","expiration_date":"2036-04-10","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001878313-26-000047","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000047/form4.xml","form_type":"4"}},{"id":980439,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-04T12:31:28.000Z","date":"2025-11-25","kind":"purchase","planned":false,"acquired":true,"shares":10500,"price":0.9661,"value":10144.05,"ownership":{"direct":true},"balance_after":831421,"source":{"system":"sec-edgar","filing":"0001878313-25-000060","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000060/form4a.xml","form_type":"4/A","original_submission_date":"2025-11-28"}},{"id":980438,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-04T12:30:22.000Z","date":"2025-11-28","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":1.1366,"value":56830.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $1.1283 to $1.1416, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The original Form 4 filed on December 1, 2025 had the incorrect total share balance owned by Vlad Vitoc.  This Amended Form 4 is now reflecting the correct share balance owned."}],"balance_after":903421,"source":{"system":"sec-edgar","filing":"0001878313-25-000059","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000059/form4a.xml","form_type":"4/A","original_submission_date":"2025-12-01"}},{"id":980437,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-04T12:30:22.000Z","date":"2025-11-26","kind":"purchase","planned":false,"acquired":true,"shares":22000,"price":1.0463,"value":23018.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $1.0145 to $1.0587, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":853421,"source":{"system":"sec-edgar","filing":"0001878313-25-000059","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000059/form4a.xml","form_type":"4/A","original_submission_date":"2025-12-01"}},{"id":985232,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-01T11:20:50.000Z","date":"2025-11-26","kind":"purchase","planned":false,"acquired":true,"shares":22000,"price":1.0463,"value":23018.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $1.0145 to $1.0587, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":853421,"source":{"system":"sec-edgar","filing":"0001878313-25-000056","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000056/form4.xml","form_type":"4"}},{"id":985231,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-01T11:20:50.000Z","date":"2025-11-28","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":1.1366,"value":56830.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $1.1283 to $1.1416, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":881421,"source":{"system":"sec-edgar","filing":"0001878313-25-000056","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000056/form4.xml","form_type":"4"}},{"id":986267,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-28T11:48:13.000Z","date":"2025-11-25","kind":"purchase","planned":false,"acquired":true,"shares":10500,"price":0.9661,"value":10144.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $0.9606 to $0.9745, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":831421,"source":{"system":"sec-edgar","filing":"0001878313-25-000047","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000047/form4.xml","form_type":"4"}},{"id":988833,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-25T21:15:03.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.9891,"value":9891.0,"ownership":{"direct":true},"balance_after":820921,"source":{"system":"sec-edgar","filing":"0001878313-25-000040","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000040/form4.xml","form_type":"4"}},{"id":988832,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-25T21:15:03.000Z","date":"2025-11-21","kind":"purchase","planned":false,"acquired":true,"shares":1800,"price":0.92,"value":1656.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $0.9128 to $0.9235, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":810921,"source":{"system":"sec-edgar","filing":"0001878313-25-000040","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000040/form4.xml","form_type":"4"}},{"id":1145655,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2025-05-16T20:15:26.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on May 14, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":400000,"derivative":{"exercise_price":1.76,"expiration_date":"2035-05-14","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001127602-25-014670","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225014670/form4.xml","form_type":"4"}},{"id":1271932,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2025-02-12T21:10:50.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on February 10, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":400000,"derivative":{"exercise_price":1.81,"expiration_date":"2035-02-10","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001127602-25-004348","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225004348/form4.xml","form_type":"4"}},{"id":1373034,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2024-11-07T21:25:48.000Z","date":"2024-11-05","kind":"gift","planned":false,"acquired":true,"shares":41253,"price":2.5,"value":103132.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"This transaction involves the reporting person's gift of 41,253 shares of MAIA Biotechnology, Inc.'s (the \"Company\") common stock held in options granted (which options fully vested on May 31, 2023) under the Company's 2021 Stock Option Plan to the Lidia Maria Vitoc 2024 MAIA Irrevocable Trust, for the benefit of Mr. Vitoc's child.  The reporting person disclaims beneficial ownership of these securities held by his daughter."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"These securities are held by Lidia Maria Vitoc 2024 MAIA Irrevocable Trust, for the benefit of Mr. Vitoc's child.  The reporting person disclaims beneficial ownership of these securities held by his daughter."}],"balance_after":41253,"derivative":{"exercise_price":2.5,"exercise_date":"2024-11-05","expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":41253},"source":{"system":"sec-edgar","filing":"0001127602-24-026731","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224026731/form4.xml","form_type":"4"}},{"id":1373033,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2024-11-07T21:25:48.000Z","date":"2024-11-05","kind":"gift","planned":false,"acquired":false,"shares":41253,"price":2.5,"value":103132.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"This transaction involves the reporting person's gift of 41,253 shares of MAIA Biotechnology, Inc.'s (the \"Company\") common stock held in options granted (which options fully vested on May 31, 2023) under the Company's 2021 Stock Option Plan to the Lidia Maria Vitoc 2024 MAIA Irrevocable Trust, for the benefit of Mr. Vitoc's child.  The reporting person disclaims beneficial ownership of these securities held by his daughter."}],"balance_after":0,"derivative":{"exercise_price":2.5,"exercise_date":"2023-05-31","expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":41253},"source":{"system":"sec-edgar","filing":"0001127602-24-026731","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224026731/form4.xml","form_type":"4"}},{"id":1373032,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2024-11-07T21:25:48.000Z","date":"2024-11-05","kind":"gift","planned":false,"acquired":true,"shares":41253,"price":2.5,"value":103132.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"This transaction involves the reporting person's gift of 41,253 shares of MAIA Biotechnology, Inc.'s (the \"Company\") common stock held in options granted (which options fully vested on May 31, 2023) under the Company's 2021 Stock Option Plan to the Maia Laetitia Cristian Vitoc 2022 MAIA Irrevocable Trust, for the benefit of Mr. Vitoc's child, for which Mr. Vitoc's spouse serves as the trustee.  The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"These securities are held by Maia Laetitia Cristian Vitoc 2022 MAIA Irrevocable Trust for the benefit of Mr. Vitoc's child, for which Mr. Vitoc's spouse serves as trustee.  The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":41253,"derivative":{"exercise_price":2.5,"exercise_date":"2024-11-05","expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":41253},"source":{"system":"sec-edgar","filing":"0001127602-24-026731","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224026731/form4.xml","form_type":"4"}},{"id":1373031,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2024-11-07T21:25:48.000Z","date":"2024-11-05","kind":"gift","planned":false,"acquired":false,"shares":41253,"price":2.5,"value":103132.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"This transaction involves the reporting person's gift of 41,253 shares of MAIA Biotechnology, Inc.'s (the \"Company\") common stock held in options granted (which options fully vested on May 31, 2023) under the Company's 2021 Stock Option Plan to the Maia Laetitia Cristian Vitoc 2022 MAIA Irrevocable Trust, for the benefit of Mr. Vitoc's child, for which Mr. Vitoc's spouse serves as the trustee.  The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":41253,"derivative":{"exercise_price":2.5,"exercise_date":"2023-05-31","expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":41253},"source":{"system":"sec-edgar","filing":"0001127602-24-026731","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224026731/form4.xml","form_type":"4"}},{"id":1373030,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2024-11-07T21:25:48.000Z","date":"2024-11-05","kind":"gift","planned":false,"acquired":true,"shares":41254,"price":2.5,"value":103135.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"This transaction involves the reporting person's gift of 41,254 shares of MAIA Biotechnology, Inc.'s (the\n\"Company\") common stock held in options granted (which options fully vested on May 31, 2023) under the Company's 2021 Stock Option Plan) to the Leia Violeta Ioana Vitoc 2022 MAIA Irrevocable Trust, for the benefit of Mr. Vitoc's child, for which Mr. Vitoc's spouse serves as the trustee.  The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"These securities are held by Leia Violeta Ioana Vitoc 2022 MAIA Irrevocable Trust for the benefit of Mr. Vitoc's child, for which Mr. Vitoc's spouse serves as trustee.  The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":41254,"derivative":{"exercise_price":2.5,"exercise_date":"2024-11-05","expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":41254},"source":{"system":"sec-edgar","filing":"0001127602-24-026731","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224026731/form4.xml","form_type":"4"}},{"id":1373029,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2024-11-07T21:25:48.000Z","date":"2024-11-05","kind":"gift","planned":false,"acquired":false,"shares":41254,"price":2.5,"value":103135.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"This transaction involves the reporting person's gift of 41,254 shares of MAIA Biotechnology, Inc.'s (the\n\"Company\") common stock held in options granted (which options fully vested on May 31, 2023) under the Company's 2021 Stock Option Plan) to the Leia Violeta Ioana Vitoc 2022 MAIA Irrevocable Trust, for the benefit of Mr. Vitoc's child, for which Mr. Vitoc's spouse serves as the trustee.  The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":82506,"derivative":{"exercise_price":2.5,"exercise_date":"2023-05-31","expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":41254},"source":{"system":"sec-edgar","filing":"0001127602-24-026731","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224026731/form4.xml","form_type":"4"}},{"id":1373028,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2024-11-07T21:25:48.000Z","date":"2024-11-05","kind":"gift","planned":false,"acquired":true,"shares":19982,"price":1.8,"value":35967.6,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction involves the reporting person's gift of 19,982 shares of MAIA Biotechnology, Inc.'s (the \"Company\") common stock held in options granted (which options fully vested on April 30, 2020) under the Company's 2018 Stock Option Plan to the Maia Laetitia Cristian Vitoc 2022 MAIA Irrevocable Trust, for the benefit of Mr. Vitoc's child, for which Mr. Vitoc's spouse serves as the trustee.  The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These securities are held by Maia Laetitia Cristian Vitoc 2022 MAIA Irrevocable Trust for the benefit of Mr. Vitoc's child, for which Mr. Vitoc's spouse serves as trustee.  The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":19982,"derivative":{"exercise_price":1.8,"exercise_date":"2024-11-05","expiration_date":"2030-04-01","underlying":"Common Stock","underlying_shares":19982},"source":{"system":"sec-edgar","filing":"0001127602-24-026731","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224026731/form4.xml","form_type":"4"}},{"id":1373027,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2024-11-07T21:25:48.000Z","date":"2024-11-05","kind":"gift","planned":false,"acquired":false,"shares":19982,"price":1.8,"value":35967.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction involves the reporting person's gift of 19,982 shares of MAIA Biotechnology, Inc.'s (the \"Company\") common stock held in options granted (which options fully vested on April 30, 2020) under the Company's 2018 Stock Option Plan to the Maia Laetitia Cristian Vitoc 2022 MAIA Irrevocable Trust, for the benefit of Mr. Vitoc's child, for which Mr. Vitoc's spouse serves as the trustee.  The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":109555,"derivative":{"exercise_price":1.8,"exercise_date":"2020-04-30","expiration_date":"2030-04-01","underlying":"Common Stock","underlying_shares":19982},"source":{"system":"sec-edgar","filing":"0001127602-24-026731","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224026731/form4.xml","form_type":"4"}},{"id":1373026,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2024-11-07T21:25:48.000Z","date":"2024-11-05","kind":"gift","planned":false,"acquired":true,"shares":19982,"price":1.8,"value":35967.6,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction involves the reporting person's gift of 19,982 shares of MAIA Biotechnology, Inc.'s (the \"Company\") common stock held in options granted (which options fully vested on April 30, 2020) under the Company's 2018 Stock Option Plan to the Lidia Maria Vitoc 2024 MAIA Irrevocable Trust, for the benefit of Mr. Vitoc's child.  The reporting person disclaims beneficial ownership of these securities held by his daughter."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are held by Lidia Maria Vitoc 2024 MAIA Irrevocable Trust, for the benefit of Mr. Vitoc's child.  The reporting person disclaims beneficial ownership of these securities held by his daughter."}],"balance_after":19982,"derivative":{"exercise_price":1.8,"exercise_date":"2024-11-05","expiration_date":"2030-04-01","underlying":"Common Stock","underlying_shares":19982},"source":{"system":"sec-edgar","filing":"0001127602-24-026731","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224026731/form4.xml","form_type":"4"}},{"id":1373025,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2024-11-07T21:25:48.000Z","date":"2024-11-05","kind":"gift","planned":false,"acquired":false,"shares":19982,"price":1.8,"value":35967.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction involves the reporting person's gift of 19,982 shares of MAIA Biotechnology, Inc.'s (the \"Company\") common stock held in options granted (which options fully vested on April 30, 2020) under the Company's 2018 Stock Option Plan to the Lidia Maria Vitoc 2024 MAIA Irrevocable Trust, for the benefit of Mr. Vitoc's child.  The reporting person disclaims beneficial ownership of these securities held by his daughter."}],"balance_after":129537,"derivative":{"exercise_price":1.8,"exercise_date":"2020-04-30","expiration_date":"2030-04-01","underlying":"Common Stock","underlying_shares":19982},"source":{"system":"sec-edgar","filing":"0001127602-24-026731","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224026731/form4.xml","form_type":"4"}},{"id":1373024,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2024-11-07T21:25:48.000Z","date":"2024-11-05","kind":"gift","planned":false,"acquired":true,"shares":19981,"price":1.8,"value":35965.8,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involves the reporting person's gift of 19,981 shares of MAIA Biotechnology, Inc.'s (the \"Company\") common stock held in options granted (which options fully vested on April 30, 2020) under the Company's 2018 Stock Option Plan to the Leia Violeta Ioana Vitoc 2022 MAIA Irrevocable Trust, for the benefit of Mr. Vitoc's child, for which Mr. Vitoc's spouse serves as the trustee.  The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held by Leia Violeta Ioana Vitoc 2022 MAIA Irrevocable Trust for the benefit of Mr. Vitoc's child, for which Mr. Vitoc's spouse serves as trustee.  The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":19981,"derivative":{"exercise_price":1.8,"exercise_date":"2024-11-05","expiration_date":"2030-04-01","underlying":"Common Stock","underlying_shares":19981},"source":{"system":"sec-edgar","filing":"0001127602-24-026731","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224026731/form4.xml","form_type":"4"}},{"id":1373023,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2024-11-07T21:25:48.000Z","date":"2024-11-05","kind":"gift","planned":false,"acquired":false,"shares":19981,"price":1.8,"value":35965.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involves the reporting person's gift of 19,981 shares of MAIA Biotechnology, Inc.'s (the \"Company\") common stock held in options granted (which options fully vested on April 30, 2020) under the Company's 2018 Stock Option Plan to the Leia Violeta Ioana Vitoc 2022 MAIA Irrevocable Trust, for the benefit of Mr. Vitoc's child, for which Mr. Vitoc's spouse serves as the trustee.  The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":149519,"derivative":{"exercise_price":1.8,"exercise_date":"2020-04-30","expiration_date":"2030-04-01","underlying":"Common Stock","underlying_shares":19981},"source":{"system":"sec-edgar","filing":"0001127602-24-026731","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224026731/form4.xml","form_type":"4"}},{"id":1532937,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2024-04-30T21:02:43.000Z","date":"2024-04-26","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on April 26, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversay of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":200000,"derivative":{"exercise_price":2.94,"expiration_date":"2034-04-26","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001127602-24-013654","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224013654/form4.xml","form_type":"4"}},{"id":1669779,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2024-01-26T21:08:49.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on January 24, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":200000,"derivative":{"exercise_price":1.41,"expiration_date":"2034-01-24","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001127602-24-002270","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224002270/form4.xml","form_type":"4"}},{"id":1867470,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2023-06-05T21:23:46.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":123760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on May 31, 2023 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":123760,"derivative":{"exercise_price":2.5,"exercise_date":"2023-05-31","expiration_date":"2032-05-30","underlying":"Common Stock","underlying_shares":123760},"source":{"system":"sec-edgar","filing":"0001127602-23-017884","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223017884/form4.xml","form_type":"4"}},{"id":1910282,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-01T10:30:18.000Z","date":"2023-04-28","kind":"purchase","planned":true,"acquired":true,"shares":4000,"price":2.5,"value":10000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.49 to $2.50, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":809121,"source":{"system":"sec-edgar","filing":"0001127602-23-013819","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223013819/form4.xml","form_type":"4"}},{"id":1925398,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-04-05T10:48:49.000Z","date":"2023-04-04","kind":"purchase","planned":true,"acquired":true,"shares":925,"price":3.56,"value":3293.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.53 to $3.60, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":805121,"source":{"system":"sec-edgar","filing":"0001127602-23-012463","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223012463/form4.xml","form_type":"4"}},{"id":1925397,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-04-05T10:48:49.000Z","date":"2023-04-03","kind":"purchase","planned":true,"acquired":true,"shares":1375,"price":3.5,"value":4812.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.45 to $3.60, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":804196,"source":{"system":"sec-edgar","filing":"0001127602-23-012463","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223012463/form4.xml","form_type":"4"}},{"id":1932646,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-04-03T13:32:19.000Z","date":"2023-03-31","kind":"purchase","planned":true,"acquired":true,"shares":1495,"price":3.46,"value":5172.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.44 to $3.48, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":802821,"source":{"system":"sec-edgar","filing":"0001127602-23-011737","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223011737/form4.xml","form_type":"4"}},{"id":1932645,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-04-03T13:32:19.000Z","date":"2023-03-30","kind":"purchase","planned":true,"acquired":true,"shares":205,"price":3.43,"value":703.15,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.41 to $3.43, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":801326,"source":{"system":"sec-edgar","filing":"0001127602-23-011737","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223011737/form4.xml","form_type":"4"}},{"id":1959064,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2023-03-10T22:01:16.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on March 8, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":200000,"derivative":{"exercise_price":4.1,"expiration_date":"2033-03-08","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001127602-23-009770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223009770/form4.xml","form_type":"4"}},{"id":1961273,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-09T11:28:25.000Z","date":"2023-03-08","kind":"purchase","acquired":true,"shares":1581,"price":4.21,"value":6656.01,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.20 to $4.22, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":801121,"source":{"system":"sec-edgar","filing":"0001127602-23-009532","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223009532/form4.xml","form_type":"4"}},{"id":1963573,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-08T11:34:55.000Z","date":"2023-03-07","kind":"purchase","acquired":true,"shares":1439,"price":4.24,"value":6101.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.21 to $4.25, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":799540,"source":{"system":"sec-edgar","filing":"0001127602-23-009392","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223009392/form4.xml","form_type":"4"}},{"id":1963572,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-08T11:34:55.000Z","date":"2023-03-06","kind":"purchase","acquired":true,"shares":544,"price":4.24,"value":2306.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.23 to $4.25, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":798101,"source":{"system":"sec-edgar","filing":"0001127602-23-009392","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223009392/form4.xml","form_type":"4"}},{"id":1969474,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-06T11:19:35.000Z","date":"2023-03-03","kind":"purchase","acquired":true,"shares":2398,"price":4.47,"value":10719.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"shares","element":"transactionShares","label":"F3","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.39 to $4.50, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":797557,"source":{"system":"sec-edgar","filing":"0001127602-23-008972","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223008972/form4.xml","form_type":"4"}},{"id":1969473,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-06T11:19:35.000Z","date":"2023-03-02","kind":"purchase","acquired":true,"shares":45,"price":4.42,"value":198.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"shares","element":"transactionShares","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.41 to $4.50, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":795159,"source":{"system":"sec-edgar","filing":"0001127602-23-008972","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223008972/form4.xml","form_type":"4"}},{"id":1980038,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-02T11:32:19.000Z","date":"2023-03-01","kind":"purchase","acquired":true,"shares":282,"price":4.48,"value":1263.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.43 to $4.50, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":795114,"source":{"system":"sec-edgar","filing":"0001127602-23-008066","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223008066/form4.xml","form_type":"4"}},{"id":1980037,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-02T11:32:19.000Z","date":"2023-02-28","kind":"purchase","acquired":true,"shares":1275,"price":4.49,"value":5724.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.43 to $4.50, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":794832,"source":{"system":"sec-edgar","filing":"0001127602-23-008066","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223008066/form4.xml","form_type":"4"}},{"id":2000283,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-22T11:24:58.000Z","date":"2023-02-17","kind":"purchase","acquired":true,"shares":73,"price":4.25,"value":310.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.24 to $4.25, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":793557,"source":{"system":"sec-edgar","filing":"0001127602-23-006340","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223006340/form4.xml","form_type":"4"}},{"id":2008095,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-17T11:05:27.000Z","date":"2023-02-16","kind":"purchase","acquired":true,"shares":10,"price":4.25,"value":42.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended."}],"balance_after":793484,"source":{"system":"sec-edgar","filing":"0001127602-23-005727","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223005727/form4.xml","form_type":"4"}},{"id":2008094,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-17T11:05:27.000Z","date":"2023-02-15","kind":"purchase","acquired":true,"shares":10,"price":4.25,"value":42.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended."}],"balance_after":793474,"source":{"system":"sec-edgar","filing":"0001127602-23-005727","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223005727/form4.xml","form_type":"4"}},{"id":2016917,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-14T12:00:50.000Z","date":"2023-02-10","kind":"purchase","acquired":true,"shares":343,"price":4.24,"value":1454.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.20 to $4.25, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":793464,"source":{"system":"sec-edgar","filing":"0001127602-23-005033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223005033/form4.xml","form_type":"4"}},{"id":2060713,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-06T13:58:21.000Z","date":"2023-01-04","kind":"purchase","acquired":true,"shares":1266,"price":3.68,"value":4658.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"shares","element":"transactionShares","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.59 to $3.75, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":793121,"source":{"system":"sec-edgar","filing":"0001127602-23-001010","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223001010/form4.xml","form_type":"4"}},{"id":2068583,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-04T12:29:00.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":2324,"price":3.64,"value":8459.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.51 to $3.70, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":791855,"source":{"system":"sec-edgar","filing":"0001127602-23-000224","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223000224/form4.xml","form_type":"4"}},{"id":2068582,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-04T12:29:00.000Z","date":"2022-12-30","kind":"purchase","acquired":true,"shares":410,"price":3.5,"value":1435.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Vitoc that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended."}],"balance_after":789531,"source":{"system":"sec-edgar","filing":"0001127602-23-000224","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223000224/form4.xml","form_type":"4"}},{"id":2105485,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-11-23T19:53:16.000Z","date":"2022-08-01","kind":"purchase","acquired":true,"shares":10000,"price":5,"value":50000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased in the issuer's initial public offering, which closed on August 1, 2022."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Vitoc's spouse.  The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":210000,"source":{"system":"sec-edgar","filing":"0001127602-22-026326","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760222026326/form4a.xml","form_type":"4/A","original_submission_date":"2022-08-02"}},{"id":2105484,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-11-23T19:53:16.000Z","date":"2022-08-01","kind":"purchase","acquired":true,"shares":6000,"price":5,"value":30000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased in the issuer's initial public offering, which closed on August 1, 2022."}],"balance_after":789121,"source":{"system":"sec-edgar","filing":"0001127602-22-026326","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760222026326/form4a.xml","form_type":"4/A","original_submission_date":"2022-08-02"}},{"id":2154197,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2022-09-20T15:18:54.000Z","date":"2022-09-16","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on September 16, 2022 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":200000,"derivative":{"exercise_price":3.56,"expiration_date":"2032-09-16","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001127602-22-022739","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760222022739/form4.xml","form_type":"4"}},{"id":2197915,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42448,"kind":"person","name":"Vitoc Vlad","position":1,"cik":"0001913257","reported_name":"Vitoc Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-02T22:32:59.000Z","date":"2022-08-01","kind":"purchase","acquired":true,"shares":6000,"price":5,"value":30000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased by the reporting person in the issuer's initial public offering, which closed on August 1, 2022."}],"balance_after":789121,"source":{"system":"sec-edgar","filing":"0000899243-22-027454","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000089924322027454/doc4.xml","form_type":"4"}}]}